Transfusion as supportive care to improve the quality of life

Transfusion as supportive care to improve the quality of life - Transfusion as supportive care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36395

Enrollment

100

Registered

2011-03-03

Start date

2011-04-07

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AML, MDS, myeloproliferatieve lymfomen en oncologische aandoeningen supportive care and quality of life by chronical need for transfusion

Interventions

administration of 1 erythrocyte concentrate

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Chronical need for transfusion Age 18 - 85 year Able to give informed consent

Exclusion criteria

Exclusion criteria: Language barrier During chemotherapy treatment extra medullary hematopoiesis

Design outcomes

Primary

Measure	Time frame
To understand the results of transfusion in patients who need chronic transfusions and receive no chemotherapy.	—

Secondary

Measure	Time frame
See if a restrictive transfusion policy has an effects on the quality of life.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)